ABOUT US
At CytoGenomic we believe that knowledge is power.
CytoGenomic Medical Laboratory specializes in next-generation diagnostic genetic testing. Applying the latest in technology, the lab provides a full range of services in clinical genetics, molecular genetics, cytogenetics and prenatal genetic screening aimed at detecting, assessing, treating, and preventing disease.
The DNA Spirit. Using science to live life to the fullest
“As a reference point for the most well-researched provision of genetic services and analyses in the country and in other Southeastern European regions, CytoGenomic Medical Laboratory takes pride in its leading role in providing accurate findings to the medical community and accessible healthcare to the people of Romania.
As diagnostic genetics continue to advance, it is our duty to remain dedicated to making its services easily accessible to all. Our aim is to employ developments in the field in the best interests of the community as a whole.”
Danae Stambouli, PhD., CytoGenomic Medical Laboratory
As diagnostic genetics continue to advance, it is our duty to remain dedicated to making its services easily accessible to all. Our aim is to employ developments in the field in the best interests of the community as a whole.”
Danae Stambouli, PhD., CytoGenomic Medical Laboratory
OUR VALUES
Do you want a better future for yourself, your children and their children? Then look no further.
You hold the future in your DNA. It answers questions. It explains. It predicts.
You hold the future in your DNA. It answers questions. It explains. It predicts.
Our mission? To make the knowledge about your genes and their insight easily accessible and understandable.
We are dedicated to applying the latest developments in genetics and biotechnology in the best interests of the community, making its services accessible to all, and empowering individuals to make informed health decisions toward the highest standard of living.
We are dedicated to applying the latest developments in genetics and biotechnology in the best interests of the community, making its services accessible to all, and empowering individuals to make informed health decisions toward the highest standard of living.
Looking ahead, as an innovator in the field of genetics, CytoGenomic Medical Laboratory is constantly expanding its focus, diversifying its services, and introducing innovative products that will pave the way for targeted medicines and personalized healthcare.
OUR TEAM
LAB DEPARTMENT
Dr.RODICA MARIA SIMION – MEDICAL CHIEF LABORATOR
GENETIC DEPARTMENT
MARIA STRATAN GENETICS DOCTOR
PREPELIȚĂ DIANA GENETICS DOCTOR
RADU ALEXANDRU TRUICA GENETICS RESIDENT DOCTOR
ANCA PAVEL MSc BIOLOGIST
ANDREEA ȚUȚULAN-CUNIȚĂ Ph.D. BIOLOGIST
IULIA PAVEL MSc BIOLOG
DIANA BRATU MSc BIOLOGIST
LUIZA DIMOS MSc BIOCHEMIST
IRINA BUCA BIOLOGIST
PETRUȚA GURBAN MSc BIOLOGIST
RAZVAN ANDREI POPESCU BIOLOGIST
EXPANDED NEONATAL SCREENING DEPARTMENT
ISABELA ȚÂRCOMNICU Ph.D. CHEMIST
TINCUȚA CÂJU MSc CHEMIST
DAVID SEBASTIAN PATRICHE BIOCHEMIST
VALENTINA PATRICIA RADOI FARMACIST
CATALINA SANDA CHEMIST
DEPARTMENT OF RESEARCH-DEVELOPMENT
DANAI STAMBOULI Ph.D. – SCIENTIFIC CONSULTANT
New NutriVi Test
The NutriVi test combines the analysis of 109 genetic predispositions related to health and nutrition (obesity, diabetes, celiac disease, responses to exercise and interventional diets, vitamin and mineral deficiencies, etc..) with relevant patient history (intolerances, diseases, medications, blood pressure, physical activity and habits, etc.).The NutriVi test stands out by covering 384 genetic variations compared to other nutrigenetic tests available on the market. This extensive breadth in genetic analysis puts it at the forefront of the market, giving it significant accuracy in identifying individual nutritional needs. By examining many genetic variations, the Nutrivi test provides a detailed and comprehensive report, allowing you to gain an in-depth understanding of your body's nutritional requirements and make informed decisions for healthy, personalized nutrition.
2023
2022
New VITA LINE Test
In 2022, Cytogenomic brought the first carrier screening test to market, developed in its laboratory, and designed for the Caucasian/European population. Linea Vita is a comprehensive screening test, used for genetic profiling for 150 genes associated with 217 genetic conditions with an autosomal recessive or X-linked inheritance pattern, that helps couples understand their genetic risks and make informed decisions about family planning.
Soon, a new test!
2020
2018
Once again, here we are to help the couples asking for In Vitro Fertilization by introducing Pre-implantation genetic diagnosis to identify monogenic disorders (PGD) for the first time in Romania using the NGS technology. This diagnosis is useful for couples bearing mutations to avoid transmitting them to their children. By testing the embryos obtained by In Vitro Fertilization, we can thus ensure the transfer of merely those embryos which are not affected, increasing these couples’ chances to have healthy children.
We passed from Genetics to Genomics by implementing cutting-edge SNP microarray and sequencing technologies. CytoGenomic Laboratory is the only laboratory in Romania to use genomic analyses Affymetrix (SNP microarray) and Ion S5 (NGS) platforms, which help us open the door for the modern concept of personalized medicine. NGS sequencing helps analysing the whole exome – around 19,000 genes and 5,000 disorders in any medical specialty (cardiology, neurology, orthopaedics, ophthalmology, metabolic diseases, gastroenterology, nephrology, etc.).
2017
2016
Extended Pre-eclampsia Screening: Starting from this year, at the CytoGenomic Laboratory, one mere peripheral blood sample is enough to determine the level of the PlGF placental marker and to estimate the risk for early detection of pre-eclampsia during the first trimester of pregnancy, this test being performed at the same time as the double test.
A new premiere for Romania - CytoGenomic Laboratory supports subfertile couples by introducing a new technique, the Pre-implantation genetic screening (PGS), performed prior to transferring the embryos in order to improve the success rate of the IVF procedure.
2015
2013
CytoGenomic Laboratory became the official partner of Ariosa Diagnostics (USA) for providing to Romania the maternal blood-based non-invasive screening Harmony for identifying the aneuploidies of chromosomes 13, 18, 21, X, and Y.
The lab introduces the array-CGH Molecular Karyotype, an advanced prenatal and postnatal cytogenetic diagnosis method identifying submicroscopic chromosomal abnormalities, which cannot be identified using the traditional karyotype.
2013
2011
A new premiere for Romania, the launching of the Expanded NewbornScreening for Inherited Metabolic Disorders using HPLC MS/MS, a scientific innovation allowing the simultaneous early detection of 51 metabolic disorders, a set of serious conditions with irreversible symptoms.
CytoGenomic Laboratory introduces during this year the prenatal biochemical screening (double and triple test) using the highly accurate and largely reproducible method certified by the Foetal Medicine Foundation (FMF) in London due to the Kryptoranalyser used for serologic determinations producing fast and accurate results in merely 24 hours. This test aims at identifying pregnancies with a high risk of Down syndrome and other chromosomal abnormalities and neural tube defects (spina bifida).
2009
2008
For the first time in Romania, our modern cytogenetics department provides the latest technologies in terms of diagnosis screening, while shifting prenataldiagnosis during the first trimester of pregnancy by analysing chorionic villus sampling (CVS). The quick and highly accurate method QF-PCR (Quantitative Fluorescence-PCR) is introduced at the same time for the prenatal detection of viable trisomies.
COLABORATORI
